Hello and Welcome to Patientsville.com, Your Source for all FELDENE information. We are dedicated to provide You with FELDENE safety information. Learn about FELDENE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
FELDENE Safety Reports
Total FELDENE reports: 57.FELDENE FDA safety alerts: No.
Reported deaths: 4 Reported hospitalizations: 26.
Take FELDENE Side Effects Survey or Share Your FELDENE Story. Read More Here.
Consumer or non-health professional from BRAZIL reported FELDENE problem on Dec 21, 2006. Male patient, 30 years of age, was diagnosed with balanitis, headache, sinusitis and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: oedema genital. FELDENE dosage: unknown. During the same period patient was treated with DIPYRONE. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Male patient, 41 years of age, was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, chest pain. FELDENE dosage: unknown. During the same period patient was treated with FELODIPINE. Patient recovered.
Health Professional from FRANCE reported FELDENE problem on Mar 05, 2007. Male patient, 15 years of age, weighting 125.7 lb, was diagnosed with abdominal pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer perforation, peritonitis. FELDENE dosage: unknown. During the same period patient was treated with DOMPERIDONE, SPASFON. Patient recovered.
FELDENE problem was reported by a Physician from PAKISTAN on Mar 22, 2007. Male patient, weighting 165.3 lb, was diagnosed with arthralgia and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. FELDENE dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from SPAIN reported FELDENE problem on Mar 21, 2007. Female patient, 62 years of age, was diagnosed with arthralgia, inflammation, osteoarthritis and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: deafness, diarrhoea, gastrointestinal disorder, oesophageal disorder, toxic epidermal necrolysis, tracheal ulcer. FELDENE dosage: unknown. During the same period patient was treated with XICIL, ACETAMINOPHEN, OMEPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.
FELDENE problem was reported by a Health Professional from FRANCE on Apr 03, 2007. Female patient, 89 years of age, was diagnosed with myalgia and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: confusional state, hyponatraemia. FELDENE dosage: unknown. During the same period patient was treated with VENLAFAXINE, BROMAZEPAM, ZOLPIDEM TARTRATE, TRIMETAZIDINE DIHYDROCHLORIDE, BUDESONIDE, SALMETEROL XINAFOATE, HEXAQUINE, RELVENE. Patient was hospitalized. Patient recovered.
Pharmacist from SPAIN reported FELDENE problem on Apr 24, 2007. Female patient, 77 years of age, was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. FELDENE dosage: unknown. During the same period patient was treated with CEFUROXIME, OMEPRAZOLE, FUROSEMIDE, NSAID, VERAPAMIL, ADIRO, FOSAMAX, DEANXIT. Patient was hospitalized. Patient died on 03/13/2007.
FELDENE problem was reported by a Physician from MOROCCO on May 04, 2007. Female patient, 40 years of age, was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, asthma. FELDENE dosage: unknown. Patient recovered.
Physician from BELGIUM reported FELDENE problem on May 15, 2007. Male patient, 14 years of age, was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, chromaturia, tongue discolouration, vomiting. FELDENE dosage: unknown. During the same period patient was treated with UROPYRINE, BENZODIAZEPINE DERIVATIVES, DESLORATADINE. Patient was hospitalized. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from BRAZIL on May 17, 2007. Male patient, weighting 145.5 lb, was diagnosed with back pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: dengue fever. FELDENE dosage: unknown. Patient recovered.
Physician from FRANCE reported FELDENE problem on May 21, 2007. Male patient, weighting 180.8 lb, was diagnosed with back pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: burning sensation, injection site pain, muscle spasms, pain in extremity, sciatica, sensation of heaviness. FELDENE dosage: unknown. During the same period patient was treated with THIOCOLCHICOSIDE, PARACETAMOL. Patient recovered.
FELDENE problem was reported by a Physician from BELGIUM on May 23, 2007. Male patient, 14 years of age, weighting 121.3 lb, was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, blood creatinine increased, chromaturia, overdose, tongue discolouration, vomiting. FELDENE dosage: TEXT:20-460 MG. TDD. During the same period patient was treated with UROPYRINE, BENZODIAZEPINE DERIVATIVES, DESLORATADINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported FELDENE problem on May 22, 2007. Female patient, weighting 253.5 lb, was diagnosed with postoperative care, autoimmune thyroiditis, hypertension and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: fall, weight decreased. FELDENE dosage: unknown. During the same period patient was treated with SYNTHROID, LOSARTAN, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
FELDENE problem was reported by a Health Professional from UNITED STATES on Feb 08, 2007. Female patient, 65 years of age, was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: gastritis, gastrointestinal haemorrhage. FELDENE dosage: unknown. Patient recovered.
Physician from FRANCE reported FELDENE problem on June 15, 2007. Female patient, 18 years of age, was diagnosed with tendonitis and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: cough. FELDENE dosage: unknown. Patient recovered.
FELDENE problem was reported by a Physician from BELGIUM on June 19, 2007. Male patient, weighting 116.8 lb, was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, cholelithiasis, chromaturia, microlithiasis, overdose, tongue discolouration. FELDENE dosage: TEXT:20-460 MG. TDD. During the same period patient was treated with UROPYRINE, BENZODIAZEPINE DERIVATIVES, DESLORATADINE. Patient was hospitalized. Patient recovered.
Physician from ITALY reported FELDENE problem on June 23, 2006. Male patient, 73 years of age, was diagnosed with back pain, discogram abnormal and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, asthenia, hepatotoxicity, liver disorder, nausea. FELDENE dosage: 20 MG (20 MG, 1 IN 1 D), INTRAMUSCULAR. During the same period patient was treated with ATENOLOL, LASIX, LORAZEPAM, ANTIGREG, TOTALIP. Patient was hospitalized. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from BRAZIL on July 07, 2006. Female patient, 51 years of age, was diagnosed with pain, pyrexia and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: nephrolithiasis. FELDENE dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported FELDENE problem on July 13, 2006. Male patient, 68 years of age, was diagnosed with back pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: emphysema. FELDENE dosage: unknown. During the same period patient was treated with CORISTINA D, SALBUTAMOL SULPHATE. Patient was hospitalized. Patient died on 01/26/1994.
FELDENE problem was reported by a Physician from FRANCE on July 25, 2006. Female patient, 23 years of age, was diagnosed with headache and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: cheilitis, prurigo, rash erythematous, rhinitis, toxic skin eruption, white blood cell count increased. FELDENE dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from VENEZUELA reported FELDENE problem on July 27, 2006. Female patient was diagnosed with headache and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: haematoma, oedema. FELDENE dosage: 20 MG (20 MG), ORAL. Patient recovered.
FELDENE problem was reported by a Physician from FRANCE on Aug 01, 2006. Female patient, 60 years of age, was diagnosed with essential hypertension, hypercholesterolaemia, bronchitis chronic, menopausal disorder and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: colitis, food poisoning, leukocytosis, mucous membrane disorder. FELDENE dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with VERAPAMIL HYDROCHLORIDE, PRAVASTATIN, FORMOTEROL W, PROGESTERONE, ESTRADIOL, ESOMEPRAZOLE MAGNESIUM, LACTULOSE, FLUOXETINE. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported FELDENE problem on Aug 08, 2006. Female patient, 60 years of age, was diagnosed with pain in extremity, essential hypertension, hypercholesterolaemia, bronchitis chronic, menopausal disorder and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, colitis, diarrhoea haemorrhagic, food poisoning, leukocytosis. FELDENE dosage: 20 MG (20 MG, 1 IN 1 D),ORAL. During the same period patient was treated with VERAPAMIL HYDROCHLORIDE, PRAVASTATIN, FORMOTEROL W, PROGESTERONE, ESTRADIOL, ESOMEPRAZOLE MAGNESIUM, LACTULOSE, FLUOXETINE. Patient was hospitalized. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from BRAZIL on Aug 16, 2006. Female patient, 23 years of age, was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: abasia, aphasia, suicide attempt, unevaluable event. FELDENE dosage: unknown. Patient recovered.
Physician from BRAZIL reported FELDENE problem on Aug 25, 2006. Male patient, 52 years of age, was diagnosed with pharyngolaryngeal pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: blister, ear disorder, genital lesion, oral soft tissue disorder, rash, skin discolouration, skin lesion. FELDENE dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ENALAPRIL. Patient recovered.
FELDENE problem was reported by a Physician from BRAZIL on Aug 25, 2006. Male patient, 52 years of age, was diagnosed with pharyngolaryngeal pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: blister, ear disorder, erythema, palatal disorder, penile blister, skin lesion. FELDENE dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ENALAPRIL MALEATE. Patient recovered.
Physician from BELGIUM reported FELDENE problem on Aug 30, 2006. Female patient, 40 years of age, weighting 92.59 lb, was diagnosed with periarthritis, rotator cuff syndrome and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: crohn's disease, gastric ulcer, haematochezia, weight decreased. FELDENE dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ZANTAC. Patient recovered.
FELDENE problem was reported by a Physician from BELGIUM on Aug 30, 2006. Female patient, 40 years of age, weighting 92.59 lb, was diagnosed with periarthritis and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: crohn's disease, gastric ulcer, haematochezia, weight decreased. FELDENE dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ZANTAC. Patient recovered.
Physician from ITALY reported FELDENE problem on Sept 14, 2006. Male patient, 92 years of age, was diagnosed with pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: agitation, atrial fibrillation, biliary colic, blood pressure increased, duodenal ulcer perforation, dyspnoea, echocardiogram abnormal, haemodynamic instability, leukocytosis. FELDENE dosage: unknown. During the same period patient was treated with IBUSTRIN, FOSICOMBI, CRONIZAT, STUGERON. Patient died on 08/28/2006.
FELDENE problem was reported by a Health Professional from ITALY on Sept 18, 2006. Male patient, 59 years of age, was diagnosed with meniscus operation and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, duodenal ulcer, gastric ulcer, haemoglobin decreased, melaena. FELDENE dosage: 40 MG (20 MG, 2 IN 1 D), INTRAMUSCULAR. During the same period patient was treated with MUSCORIL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported FELDENE problem on Sept 27, 2006. Female patient was diagnosed with joint dislocation and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: breath odour, burning sensation, mouth ulceration, oral discomfort. FELDENE dosage: (20 MG), ORAL. Patient recovered.
FELDENE problem was reported by a Physician from BRAZIL on Sept 26, 2006. Male patient, 52 years of age, was diagnosed with back pain, pharyngolaryngeal pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: blister, ear disorder, erythema, eye disorder, face oedema, herpes virus infection, hypersensitivity, palatal disorder. FELDENE dosage: 20 MG (20 MG, 1 IN 1 D), SUBLINGUAL. During the same period patient was treated with ENALAPRIL MALEATE. Patient recovered.
Consumer or non-health professional from BRAZIL reported FELDENE problem on Oct 09, 2006. Female patient, 58 years of age, was diagnosed with joint dislocation and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: mouth injury. FELDENE dosage: unknown. During the same period patient was treated with OSCAL. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from BRAZIL on Oct 09, 2006. Female patient was diagnosed with pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, anal haemorrhage, anorectal disorder, application site odour, bedridden, diarrhoea, fall, flatulence, gait disturbance. FELDENE dosage: 20 MG, RECTAL. During the same period patient was treated with BELLADONNA, CAMPHOR, NEOSALDINA, CATAFLAM, METHYL SALICYLATE, GINKGO BILOBA. Patient recovered.
Physician from ITALY reported FELDENE problem on Oct 11, 2006. Male patient, 92 years of age, was diagnosed with pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: agitation, atrial fibrillation, biliary colic, duodenal ulcer perforation, dyspnoea, haemodynamic instability, leukocytosis, oliguria. FELDENE dosage: unknown. During the same period patient was treated with IBUSTRIN, FOSICOMBI, CRONIZAT, STUGERON. Patient died on 08/28/2006.
FELDENE problem was reported by a Consumer or non-health professional from BRAZIL on Oct 16, 2006. Male patient was diagnosed with scar and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: abasia, oedema genital. FELDENE dosage: unknown. Patient recovered.
Physician from FRANCE reported FELDENE problem on Oct 24, 2006. Female patient, 35 years of age, was diagnosed with back pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: hypoacusis. FELDENE dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, KETOPROFEN. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from BRAZIL on Oct 26, 2006. Female patient was diagnosed with pneumonia and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: constipation, diverticulum, malaise, vomiting. FELDENE dosage: unknown. During the same period patient was treated with MELOXICAM, POLYCARBOPHIL CALCIUM, ACETAMINOPHEN W. Patient recovered.
Consumer or non-health professional from BRAZIL reported FELDENE problem on Oct 27, 2006. Female patient, 45 years of age, was diagnosed with inflammation and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: hernia, inflammation, spinal disorder. FELDENE dosage: unknown. Patient was hospitalized. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from BRAZIL on Nov 01, 2006. Female patient was diagnosed with pneumonia, pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: articular calcification, condition aggravated, confusional state, convulsion, diverticulum, gait disturbance, hypertension, muscle atrophy, vomiting. FELDENE dosage: unknown. During the same period patient was treated with MELOXICAM, POLYCARBOPHIL CALCIUM, TYLEX. Patient recovered.
Health Professional from UNITED STATES reported FELDENE problem on Oct 31, 2006. Female patient was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: hospitalisation. FELDENE dosage: 80 MG (20 MG, 4 IN 1 D). Patient was hospitalized. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2006. Female patient, 41 years of age, weighting 210.0 lb, was diagnosed with arthralgia and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: chest discomfort, cholelithiasis, condition aggravated, gastrointestinal ulcer, hepatic steatosis, nausea. FELDENE dosage: 20 MG (20 MG, 1 IN 1 D). During the same period patient was treated with LAMICTAL, LANOXIN, PROMETHAZINE. Patient recovered.
Consumer or non-health professional from BRAZIL reported FELDENE problem on Nov 13, 2006. Male patient, 60 years of age, was diagnosed with gout and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. FELDENE dosage: unknown. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from BRAZIL on Nov 10, 2006. Female patient, 41 years of age, was diagnosed with migraine, myomectomy and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: blister, face oedema, periorbital oedema, pruritus, skin exfoliation. FELDENE dosage: 60 MG (20 MG, 3 IN 1 D), ORAL. Patient recovered.
Physician from ITALY reported FELDENE problem on Nov 13, 2006. Female patient, 62 years of age, was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: agitation, amnesia, hypotension, ill-defined disorder, loss of consciousness, malaise, rash, trismus. FELDENE dosage: 20 MG (20 MG, 1 IN 1 D), INTRAMUSCULAR. During the same period patient was treated with MUSCORIL. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from BRAZIL on Nov 16, 2006. Male patient, 60 years of age, was diagnosed with gout and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, condition aggravated, gout. FELDENE dosage: 40 MG (40 MG, SINGLE: PRN), PARENTERAL ; SINGLE: PRN, TOPICAL. During the same period patient was treated with CARDURA, ASPIRIN, OMEPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.
Pharmacist from BELGIUM reported FELDENE problem on July 06, 2006. Male patient, 15 years of age, was diagnosed with musculoskeletal pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: distractibility, headache, visual disturbance. FELDENE dosage: 60 MG (20 MG, 3 IN 1 D); ORAL. Patient was hospitalized. Patient recovered.
FELDENE problem was reported by a Physician from UNITED STATES on Nov 21, 2006. Male patient, 79 years of age, weighting 179.7 lb, was diagnosed with osteoarthritis, aortic valve replacement and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: anal fissure, dysgeusia, fatigue, haematocrit decreased, international normalised ratio abnormal. FELDENE dosage: unknown. During the same period patient was treated with WARFARIN, ATENOLOL, TOLTERODINE TARTRATE, TAMSULOSIN, ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE, LORTAB, LEUPROLIDE ACETAE. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported FELDENE problem on Nov 29, 2006. Male patient, 79 years of age, weighting 179.7 lb, was diagnosed with osteoarthritis, aortic valve replacement and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: anal fissure, dysgeusia, fatigue, haematocrit decreased, rectal haemorrhage. FELDENE dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SUTENT, WARFARIN, ATENOLOL, TOLTERODINE TARTRATE, TAMSULOSIN, ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE, LORTAB, LEUPROLIDE ACETATE. Patient was hospitalized. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from BRAZIL on Dec 06, 2006. Female patient, 41 years of age, was diagnosed with migraine, myomectomy and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: blister, erythema, hepatitis c, hypersensitivity, skin exfoliation, swelling face, treatment noncompliance. FELDENE dosage: 60 MG (20 MG, 3 IN 1 D), ORAL. Patient recovered.
Consumer or non-health professional from BRAZIL reported FELDENE problem on Dec 06, 2006. Female patient, 45 years of age, was diagnosed with inflammation and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: intervertebral disc protrusion, osteitis. FELDENE dosage: unknown. During the same period patient was treated with GABAPENTIN, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.
FELDENE problem was reported by a Health Professional from FRANCE on June 25, 2007. Female patient, 73 years of age, weighting 244.7 lb, was diagnosed with arthritis and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. FELDENE dosage: unknown. During the same period patient was treated with DICLOFENAC. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported FELDENE problem on June 25, 2007. Male patient, weighting 180.8 lb, was diagnosed with back pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: injection site pain, muscle spasms, paraesthesia, sciatica. FELDENE dosage: unknown. During the same period patient was treated with THIOCOLCHICOSIDE, PARACETAMOL. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2007. Male patient, weighting 164.9 lb, was diagnosed with arthralgia and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: hyperhidrosis, stevens-johnson syndrome. FELDENE dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported FELDENE problem on July 10, 2007. Female patient, weighting 121.3 lb, was diagnosed with tendonitis and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: cough. FELDENE dosage: unknown. Patient recovered.
FELDENE problem was reported by a Consumer or non-health professional from BRAZIL on July 16, 2007. Female patient, weighting 136.7 lb, was diagnosed with tendon disorder and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: arthralgia, pneumonia. FELDENE dosage: unknown. During the same period patient was treated with PURAN T, FOLIC ACID, OMEPRAZOLE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported FELDENE problem on Aug 20, 2007. Male patient, 44 years of age, was diagnosed with intervertebral disc protrusion, pain and was treated with FELDENE. After drug was administered, patient experienced the following problems/side effects: blister, erythema multiforme, injection site erythema, mouth injury, pruritus, pyrexia, rash erythematous, rash papular. FELDENE dosage: unknown. During the same period patient was treated with DETENSIEL, ASPIRIN, ATARAX, INIPOMP, DAFALGAN, CONTRAMAL, ALPRAZOLAM, KETOPROFEN. Patient was hospitalized. Patient recovered.